25-desacetylrifapentine

DB15213InvestigationalSmall molecule

25-desacetylrifapentine is under investigation in clinical trial NCT00023387 (TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine).

Formula / weight: C₄₅H₆₂N₄O₁₁ · 835.008 g/mol (avg)
Also known as: 25-DESACETYL RIFAPENTINE

Resolves to

Compound

UNII29A0K44SJOCAS79039-56-8

Structure

InChIKeyLPUNEQQTZOWCNO-WEOUFWGLSA-NSMILES

CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(CC4)C4CCCC4)=C(NC(=O)\C(C)=C/C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](O)[C@@H]1C)C(O)=C2C(O)=C3C

What you can answer from here — as of April 02, 2025

97Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of 25-desacetylrifapentine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account